Home/Bullfrog AI/Gregory Riggins
GR

Gregory Riggins

Scientific Advisor (Neurosurgery and Oncology)

Bullfrog AI

Bullfrog AI Pipeline

DrugIndicationPhase
BF-222Glioblastoma (initial), other cancersPreclinical
BF-223Glioblastoma (initial), other oncology indicationsPreclinical
BF-114Obesity, NAFLD, NASH, Hepatocellular Carcinoma (HCC)Preclinical